A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...

Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer ...

A new study focusing on the common CA-125 blood test found that some patients were 23 percent less likely to show elevated cancer antigen levels at diagnosis.

A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

A standard diagnostic test for ovarian cancer is less effective in detecting the disease among Black and Native American ...

In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current CA-125 thresholds ...

The researchers analyzed data from more than 200,000 women with ovarian cancer from 2004 through 2020 who’d had a CA-125 blood test. Black and Native American patients were 23% less likely to ...

The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their ...

The study, published in JAMA Network Open, looked at more than 200,000 women with ovarian cancer who took a test called CA-125. This test checks for a tumor marker in the blood that can be a sign ...